Schedule of Broach Lifecare Hospital
| Issue open date | 13 Aug 2024 |
| Issue close date | 16 Aug 2024 |
| UPI mandate deadline | 16 Aug 2024 (5 PM) |
| Allotment finalization | 19 Aug 2024 |
| Refund initiation | 20 Aug 2024 |
| Share credit | 20 Aug 2024 |
| Listing date | 21 Aug 2024 |
| Mandate end date | 31 Aug 2024 |
| Lock-in end date for anchor investors (50%) | 18 Sep 2024 |
| Lock-in end date for anchor investors (remaining) | 18 Nov 2024 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Broach Lifecare Hospital
Incorporated in 2023, Broach Lifecare Hospital operates boutique Hospitals under the brand “Maple Hospitals” and provides round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory BPMeasurement, Stress test, Dobutamine Stress Echocardiography.
The company’s hospital in Bharuch is an ultra-luxury hospital with 25 beds for in-patient treatment and is also equipped with diagnostic devices. It has a Satellite Hospital at Ankleshwar with a 15-bed nursing home that acts as a referral center and offers non-surgical day-to-day treatment of its patients. As of August 2024, The company’s hospitals are empanelled with 4 PSU insurance companies, 15 Private Insurance companies, and 8 Third Party administrators (TPA).
Financials of Broach Lifecare Hospital
Issue size
| Funds raised in the IPO | Amount |
| Overall | ₹4.02 crores |
| Fresh Issue | ₹4.02 crores |
| Offer for sale | – |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital Expenditure | 2.62 (65.18%) |
| Medical Tourism Web Portal development | 0.75 (18.66%) |
| Issue related expenses | 0.19 (4.86%) |
| General corporate purposes | 0.45 (11.20%) |
Strengths
- Clinical excellence and affordable healthcare: The company delivers cardiology & clinical excellence through quality healthcare service supported by a combination of experienced medical talent, strong clinical and patient safety protocols, and investments in new medical technology providing comprehensive cardiovascular healthcare services in a state-of-the-art and ultra-luxury facility at an affordable price.
- Strategic location: The company believes that its hospital is strategically located near the industrial belt of Bharuch and Ankleshwar, Gujrat surrounded by Chemical, API, Fertilizers, and Pharma manufacturing units where employee health is a great concern. Further, it believes that it will have an advantage with the development of an industrial cluster at Dahej.
Risks
- Highly regulated industry: The company operates in a highly regulated industry with requirements to obtain, renew, and maintain statutory and regulatory permits, etc. Any regulatory changes or violations of such rules and regulations may adversely affect the business, financial condition, and results of operations.
- Higher competition: The company’s failure to compete effectively against existing and new competitors, other multispecialty or super specialty hospitals, and medical practitioners could adversely affect its market share and business prospects.
- Dependence on tie-up arrangements: The company derives a significant portion of its revenues from tie-up arrangements with insurance companies, third-party administrators, and corporations. Any loss of major customers would have a material effect on business operations and profitability.